{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:21:16Z","timestamp":1783027276311,"version":"3.54.6"},"reference-count":16,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-008606"],"award-info":[{"award-number":["INV-008606"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1179069"],"award-info":[{"award-number":["OPP1179069"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2025,1,20]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Biannual (ie, every 6 months) mass drug administration of azithromycin has reduced childhood mortality in Niger, but its effects on specific respiratory pathogens are not fully elucidated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Across 2 years of the Macrolides Oraux pour R\u00e9duire les D\u00e9c\u00e8s avec un Oeil sur la R\u00e9sistance (MORDOR) study in Niger, we evaluated 1468 nasopharyngeal swabs from children who presented for care with respiratory symptoms. Swabs were tested by quantitative PCR using a customised TaqMan Array Card that included assays for 19 respiratory pathogens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nasopharyngeal detection of <jats:italic>Haemophilus influenzae<\/jats:italic>, <jats:italic>Moraxella catarrhalis<\/jats:italic> and <jats:italic>Streptococcus pneumoniae<\/jats:italic> was common in both azithromycin and placebo communities. The prevalence was reduced in children from azithromycin communities for just two pathogens: <jats:italic>Bordetella pertussis<\/jats:italic> and <jats:italic>H. influenzae<\/jats:italic> type b (Hib). These children had a 49% and 65% reduction in the prevalence of <jats:italic>B. pertussis<\/jats:italic> and Hib in nasopharyngeal swabs, respectively, compared with children from the control communities (prevalence ratios 0.51, 95% CI 0.35, 0.75; and 0.35, 95% CI 0.17, 0.71).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Biannual administration of azithromycin to communities in Niger was associated with lower prevalence of <jats:italic>B. pertussis<\/jats:italic> and Hib compared with placebo. These reductions may explain some of the childhood mortality benefit of azithromycin.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02048007\">NCT02048007<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016043","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:55:13Z","timestamp":1739188513000},"page":"e016043","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of biannual azithromycin on respiratory pathogens among symptomatic children: results from the randomised Macrolides Oraux pour R\u00e9duire les D\u00e9c\u00e8s avec un Oeil sur la R\u00e9sistance (MORDOR) I trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct02048007","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02048007","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[{"name":"School of Public Health, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-4471","authenticated-orcid":false,"given":"Stephanie A","family":"Brennhofer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Stroup","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suporn","family":"Pholwat","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M","family":"Arzika","sequence":"additional","affiliation":[{"name":"Centre de Recherche et Interventions en Sante Publique, Niamey, Niger"},{"name":"Carter Center, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramatou","family":"Maliki","sequence":"additional","affiliation":[{"name":"Carter Center, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amza","family":"Abdou","sequence":"additional","affiliation":[{"name":"Programme Nationale de Sant\u00e9 Oculaire, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lebas","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-5321","authenticated-orcid":false,"given":"Kieran S","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Arnold","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-1457","authenticated-orcid":false,"given":"Jeremy D","family":"Keenan","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California San Francisco, San Francisco, California, USA"},{"name":"Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Platts-Mills","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T","family":"Rogawski McQuade","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1085-1354","authenticated-orcid":false,"given":"Eric R","family":"Houpt","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"2025072915033357000_10.2.e016043.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715474"},{"key":"2025072915033357000_10.2.e016043.2","unstructured":"World Health Organization . WHO guideline on mass drug administration of azithromycin to children under five years of age to promote child survival. 2020. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240009585"},{"key":"2025072915033357000_10.2.e016043.3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0106"},{"key":"2025072915033357000_10.2.e016043.4","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S2214-109X(19)30540-6","article-title":"Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial","volume":"8","author":"Keenan","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025072915033357000_10.2.e016043.5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/cid\/ciab1046","article-title":"Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger","volume":"75","author":"Platts-Mills","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025072915033357000_10.2.e016043.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0533-0"},{"key":"2025072915033357000_10.2.e016043.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002835","article-title":"Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial","volume":"16","author":"Arzika","year":"2019","journal-title":"PLoS Med"},{"key":"2025072915033357000_10.2.e016043.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28565-5","article-title":"Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger","volume":"13","author":"Arzika","year":"2022","journal-title":"Nat Commun"},{"key":"2025072915033357000_10.2.e016043.9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2213-2600(16)00096-5","article-title":"Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study","volume":"4","author":"Zar","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025072915033357000_10.2.e016043.10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study","volume":"394","author":"O\u2019Brien","year":"2019","journal-title":"The Lancet"},{"key":"2025072915033357000_10.2.e016043.11","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMc1901535","article-title":"Macrolide Resistance in MORDOR I - A Cluster-Randomized Trial in Niger","volume":"380","author":"Doan","year":"2019","journal-title":"N Engl J Med"},{"key":"2025072915033357000_10.2.e016043.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002606"},{"key":"2025072915033357000_10.2.e016043.13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39351","article-title":"Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial","volume":"4","author":"Arzika","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025072915033357000_10.2.e016043.14","unstructured":"WHO immunization data portal. n.d. Available: https:\/\/immunizationdata.who.int\/pages\/profiles\/ner.html"},{"key":"2025072915033357000_10.2.e016043.15","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmu001"},{"key":"2025072915033357000_10.2.e016043.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811400"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:03:44Z","timestamp":1753826624000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjgh-2024-016043"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016043","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}